Travere Therapeutics, Inc. (TVTX)

Price$65.59Cached quote
TVTXNasdaq
Loading local price history

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

16 annual periodsNewest to oldest
2025202420232022202120202019201820172016201520142013201220112010
Revenue$490.7M$233.2M$145.2M$109.5M$131.8M$198.3M$175.3M$164.2M$154.9M$133.6M$99.9M$28.2M$0—$0$0
Gross profit$480.4M$225.4M$133.8M$105.0M$128.0M$192.2M$170.1M$158.7M$151.3M$129.0M$97.7M$27.6M$0—−$12,000−$12,000
Gross margin97.89%96.68%92.12%95.96%97.10%96.91%97.01%96.63%97.67%96.59%97.81%97.98%————
Research & development$206.0M$217.5M$245.0M$227.3M$201.2M$131.8M$141.0M$123.8M$78.2M$70.8M$50.4M$47.8M$7.1M$662,502——
Operating expenses$553.6M$557.0M$533.4M$429.3M$331.3M$374.5M$312.7M$244.3M$208.7M$191.8M$150.6M$108.0M$24.8M$30.3M$14,825$23,022
Operating income−$62.8M−$323.8M−$388.1M−$319.8M−$199.4M−$176.2M−$137.4M−$80.0M−$53.8M−$58.2M−$50.7M−$79.8M−$24.8M−$30.3M−$14,825−$23,022
Operating margin−12.80%−138.88%−267.24%−292.17%−151.27%−88.83%−78.34%−48.73%−34.72%−43.58%−50.80%−282.98%————
EBITDA−$2.1M−$280.3M−$349.6M−$299.1M−$186.7M−$151.6M−$117.0M−$61.4M−$36.0M−$42.1M−$37.4M−$74.4M−$24.6M−$30.1M——
EBITDA margin−0.42%−120.20%−240.71%−273.25%−141.60%−76.43%−66.70%−37.37%−23.23%−31.50%−37.40%−263.83%————
Net income−$25.5M−$321.5M−$111.4M−$278.5M−$180.1M−$169.4M−$146.4M−$102.7M−$59.7M−$47.9M$117.2M−$110.9M−$34.6M−$30.3M−$14,825−$23,022
Net profit margin−5.21%−137.90%−76.70%−254.41%−136.60%−85.43%−83.51%−62.51%−38.55%−35.86%117.36%−393.36%————
Basic EPSper basic share-$0.29-$4.08-$1.50-$4.37-$3.01-$3.56-$3.46-$2.54-$1.54-$1.29$3.49-$4.43-$2.44-$8.29——
Diluted EPSper diluted share-$0.29-$4.08-$1.50-$4.37-$3.01-$3.56-$3.46-$2.54-$1.54-$1.29$3.17-$4.43-$2.44-$8.29——

Owners

Reported shareholders

Reference date Jun 30, 2026
Jupiter Topco LLC · 12.02% of listed sharesBlackRock, Inc. · 8.52% of listed sharesFMR LLC · 7.54% of listed sharesBANK OF AMERICA CORP /DE/ · 4.85% of listed sharesSTATE STREET CORP · 4.52% of listed sharesVANGUARD CAPITAL MANAGEMENT LLC · 4.36% of listed sharesPERCEPTIVE ADVISORS LLC · 3.98% of listed sharesNOMURA ASSET MANAGEMENT INTERNATIONAL INC. · 2.99% of listed sharesADAGE CAPITAL PARTNERS GP, L.L.C. · 2.73% of listed sharesGEODE CAPITAL MANAGEMENT, LLC · 2.52% of listed sharesRock Springs Capital Management LP · 2.31% of listed sharesKynam Capital Management, LP · 2.12% of listed sharesStephens Investment Management Group LLC · 1.99% of listed sharesRENAISSANCE TECHNOLOGIES LLC · 1.95% of listed sharesEMERALD ADVISERS, LLC · 1.70% of listed sharesARMISTICE CAPITAL, LLC · 1.67% of listed sharesTWO SIGMA INVESTMENTS, LP · 1.66% of listed sharesVANGUARD PORTFOLIO MANAGEMENT LLC · 1.64% of listed sharesGOLDMAN SACHS GROUP INC · 1.63% of listed sharesWELLINGTON MANAGEMENT GROUP LLP · 1.63% of listed shares
12.02%of listed shares
Jupiter Topco LLC11.32M shares · Jun 30, 2026
View holders
Top 20 reported holders of TVTX
Holder% owned
Jupiter Topco LLC
12.02%11.32M shares
BlackRock, Inc.
8.52%8.02M shares
FMR LLC
7.54%7.1M shares
BANK OF AMERICA CORP /DE/
4.85%4.57M shares
STATE STREET CORP
4.52%4.26M shares
VANGUARD CAPITAL MANAGEMENT LLC
4.36%4.11M shares
PERCEPTIVE ADVISORS LLC
3.98%3.75M shares
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.
2.99%2.81M shares
ADAGE CAPITAL PARTNERS GP, L.L.C.
2.73%2.57M shares
GEODE CAPITAL MANAGEMENT, LLC
2.52%2.37M shares
Rock Springs Capital Management LP
2.31%2.18M shares
Kynam Capital Management, LP
2.12%2M shares
Stephens Investment Management Group LLC
1.99%1.88M shares
RENAISSANCE TECHNOLOGIES LLC
1.95%1.83M shares
EMERALD ADVISERS, LLC
1.70%1.6M shares
ARMISTICE CAPITAL, LLC
1.67%1.57M shares
TWO SIGMA INVESTMENTS, LP
1.66%1.57M shares
VANGUARD PORTFOLIO MANAGEMENT LLC
1.64%1.54M shares
GOLDMAN SACHS GROUP INC
1.63%1.54M shares
WELLINGTON MANAGEMENT GROUP LLP
1.63%1.53M shares

Percentages use 94.17M shares of this listed class outstanding on Jun 30, 2026.

Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.

Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)128$45.08M disclosed value
128 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Jun 12, 2026Form 4 · 10b5-1Baynes Roy D.DirectorSellCommon Stock4.5K$50.00$225.0K41.5K
Jun 12, 2026Form 4 · 10b5-1Coughlin TimothyDirectorSellCommon Stock10.0K$50.07$500.7K56.3K
May 15, 2026Form 4 · 10b5-1Coughlin TimothyDirectorSellCommon Stock3.3K$43.49$141.3K52.3K
May 6, 2026Form 4 · 10b5-1Cline Christopher R.CHIEF FINANCIAL OFFICERSellCommon Stock310$43.95$13.6K118.7K
May 6, 2026Form 4 · 10b5-1Inrig JulaCHIEF MEDICAL OFFICERSellCommon Stock311$43.95$13.7K113.2K

Community posts

It’s quiet here.

No posts about TVTX yet. Start the conversation.

Write the first post